BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

Low molecular weight heparin (LMWH) is an anticoagulant injected subcutaneously or intravenously and acts via activation of antithrombin III which in turn inactivates thrombin and factor Xa to ...

Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

SAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and low-molecular-weight heparin (LMWH) injections as a bleeding prevention strategy, a ...

There are two formulations of heparins, unfractionated heparin (UFH) and low molecular weight heparin (LMWH), used in clinical practice. Unfractionated heparin is used for both therapeutic ...

For patients undergoing elective hip- and knee-replacement surgery, the current options for prophylaxis of VTE include low-molecular-weight heparin, warfarin or pentasaccharide. Guidelines advise ...

Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. It is used to prevent formation of blood clots caused by certain ...